BOT 0.66% 37.8¢ botanix pharmaceuticals ltd

Ann: Appendix 4C - Quarterly, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 930 Posts.
    lightbulb Created with Sketch. 111
    If he wants to avoid a CR it is a necessity because they will run out of money in the 3rd Quarter, and as shown by previous raisings Matt and the crew don't like the available funds to run too low and they love to do a CR on the back of positive trial results as proven by past actions. When better to raise some funds than when the results of the BTX1503 are released. I don't see how they can avoid one anyway as the time delay between the results and a positive licencing or outright purchase deal would take a period of time to negotiate terms and if they are low on funds they cannot delay until better terms are offered so it is in their and our best interests if they do.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.